331 related articles for article (PubMed ID: 17610480)
41. [Pseudomyxoma peritonei].
Dejong CH; Booster MH; Theunissen PH; Beets GL; van Duin CJ
Ned Tijdschr Geneeskd; 1997 Jun; 141(24):1196-8. PubMed ID: 9380155
[TBL] [Abstract][Full Text] [Related]
42. Incidental finding of pseudomyxoma peritonei at primary cesarean section.
Abdu B; Hobgood D; Stallings S; Depasquale S
Am J Perinatol; 2009 Oct; 26(9):633-5. PubMed ID: 19399708
[TBL] [Abstract][Full Text] [Related]
43. [Peritoneal pseudomyxoma].
Atlante M; Carico E
Minerva Ginecol; 1998 Nov; 50(11):487-9. PubMed ID: 9882990
[TBL] [Abstract][Full Text] [Related]
44. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
45. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
Wickström C; Christersson C; Davies JR; Carlstedt I
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
[TBL] [Abstract][Full Text] [Related]
46. Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.
Flatmark K; Reed W; Halvorsen T; Sørensen O; Wiig JN; Larsen SG; Fodstad Ø; Giercksky KE
BMC Cancer; 2007 Jun; 7():116. PubMed ID: 17603904
[TBL] [Abstract][Full Text] [Related]
47. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions.
Sheehan JK; Brazeau C; Kutay S; Pigeon H; Kirkham S; Howard M; Thornton DJ
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):37-44. PubMed ID: 10727399
[TBL] [Abstract][Full Text] [Related]
48. The mouse secreted gel-forming mucin gene cluster.
Escande F; Porchet N; Bernigaud A; Petitprez D; Aubert JP; Buisine MP
Biochim Biophys Acta; 2004 Feb; 1676(3):240-50. PubMed ID: 14984930
[TBL] [Abstract][Full Text] [Related]
49. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
[TBL] [Abstract][Full Text] [Related]
50. Ovarian mucinous tumor arising in mature cystic teratoma associated with pseudomyxoma peritonei: a case with possible respiratory epithelial differentiation.
Stewart CJ; Junckerstorff R; Tsukamoto T
Int J Gynecol Pathol; 2008 Jan; 27(1):41-3. PubMed ID: 18156973
[No Abstract] [Full Text] [Related]
51. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.
Jackson SL; Fleming RA; Loggie BW; Geisinger KR
Mod Pathol; 2001 Jul; 14(7):664-71. PubMed ID: 11454998
[TBL] [Abstract][Full Text] [Related]
52. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
[TBL] [Abstract][Full Text] [Related]
53. The relationship between diverticula and low-grade mucinous neoplasm of the appendix. Does the diverticulum play a role in the development of periappendicular mucin deposition or pseudomyxoma peritonei?
Pasaoglu E; Leblebici C; Okcu O; Boyaci C; Dursun N; Hande Yardimci A; Kucukyilmaz M
Pol J Pathol; 2016; 67(4):376-383. PubMed ID: 28547966
[TBL] [Abstract][Full Text] [Related]
54. Synchronous Ovarian and Appendiceal Mucinous Neoplasms in the Absence of Pseudomyxoma Peritonei.
Gui X; Escobar J; Lee CH; Duggan MA; Köbel M
Int J Gynecol Cancer; 2017 Feb; 27(2):214-222. PubMed ID: 27870702
[TBL] [Abstract][Full Text] [Related]
55. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei.
Bibi R; Pranesh N; Saunders MP; Wilson MS; O'dwyer ST; Stern PL; Renehan AG
Br J Cancer; 2006 Nov; 95(9):1258-64. PubMed ID: 17031402
[TBL] [Abstract][Full Text] [Related]
56. Re: JSLS. 2009;13(2):203-206 Laparoscopic mucin removal in patients with pseudomyxoma peritonei.
Albedah A
JSLS; 2010; 14(1):152; author reply 152-3. PubMed ID: 20529543
[No Abstract] [Full Text] [Related]
57. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
58. Chronic perineal fistula as a late failure manifestation of pseudomyxoma peritonei syndrome.
Sebbag G; Sugarbaker PH; Walfisch S; Levy I
Scand J Gastroenterol; 2004 Nov; 39(11):1172-4. PubMed ID: 15545180
[TBL] [Abstract][Full Text] [Related]
59. MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma.
Welsh KG; Rousseau K; Fisher G; Bonser LR; Bradding P; Brightling CE; Thornton DJ; Gaillard EA
Chest; 2017 Oct; 152(4):771-779. PubMed ID: 28716644
[TBL] [Abstract][Full Text] [Related]
60. High performance gel filtration using monodisperse highly cross-linked agarose as a one-step system for mucin purification.
Parker N; Finnie IA; Raouf AH; Ryder SD; Campbell BJ; Tsai HH; Iddon D; Milton JD; Rhodes JM
Biomed Chromatogr; 1993; 7(2):68-74. PubMed ID: 8485376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
